| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.40B | -2.4% | +0.5% |
| Cost of Revenue | $683.0M | +5.2% | -2.6% |
| R&D Expense | $170.0M | -1.2% | +1.8% |
| SG&A Expense | $579.0M | -6.2% | +2.5% |
| Interest Expense | $58.0M | +9.4% | +1.8% |
| Pre-tax Income | $887.0M | -1.7% | +1.5% |
| Income Tax | $166.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.08B | +45.2% | +21.6% |
| Accounts Receivable | $1.54B | +0.1% | +9.2% |
| Inventory | $2.46B | +1.1% | +2.0% |
| Current Assets | $6.58B | +11.1% | +4.8% |
| Total Assets | $15.16B | +4.7% | +5.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.01B | — | — |
| Capital Expenditures | $460.0M | — | — |
| Investing Cash Flow | -$582.0M | — | — |
| Financing Cash Flow | -$1.38B | — | — |
| Free Cash Flow | $1.55B | — | — |
| -9.8% |
| -8.8% |
| Net Income | $721.0M | +0.4% | +5.7% |
| EPS (Basic) | $1.63 | +1.2% | +7.9% |
| EPS (Diluted) | $1.63 | +1.2% | +8.7% |
| $1.81B |
| -46.3% |
| +6.2% |
| Long-term Debt | $7.07B | +35.1% | +7.5% |
| Total Liabilities | $9.76B | +2.7% | +7.0% |
| Stockholders' Equity | $5.40B | +8.5% | +3.1% |